129 related articles for article (PubMed ID: 11000247)
1. Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein.
Delos SE; White JM
J Virol; 2000 Oct; 74(20):9738-41. PubMed ID: 11000247
[TBL] [Abstract][Full Text] [Related]
2. The central proline of an internal viral fusion peptide serves two important roles.
Delos SE; Gilbert JM; White JM
J Virol; 2000 Feb; 74(4):1686-93. PubMed ID: 10644338
[TBL] [Abstract][Full Text] [Related]
3. A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.
Melder DC; Yin X; Delos SE; Federspiel MJ
J Virol; 2009 Sep; 83(17):8575-86. PubMed ID: 19515762
[TBL] [Abstract][Full Text] [Related]
4. Studies of the "chain reversal regions" of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry.
Delos SE; La B; Gilmartin A; White JM
J Virol; 2010 Jun; 84(11):5687-94. PubMed ID: 20335266
[TBL] [Abstract][Full Text] [Related]
5. Cysteines flanking the internal fusion peptide are required for the avian sarcoma/leukosis virus glycoprotein to mediate the lipid mixing stage of fusion with high efficiency.
Delos SE; Brecher MB; Chen Z; Melder DC; Federspiel MJ; White JM
J Virol; 2008 Mar; 82(6):3131-4. PubMed ID: 18184714
[TBL] [Abstract][Full Text] [Related]
6. A single glycosylation site within the receptor-binding domain of the avian sarcoma/leukosis virus glycoprotein is critical for receptor binding.
Delos SE; Burdick MJ; White JM
Virology; 2002 Mar; 294(2):354-63. PubMed ID: 12009877
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the candidate internal fusion peptide of the avian leukosis and sarcoma virus subgroup A envelope glycoprotein.
Hernandez LD; White JM
J Virol; 1998 Apr; 72(4):3259-67. PubMed ID: 9525653
[TBL] [Abstract][Full Text] [Related]
8. Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein.
Matsuyama S; Delos SE; White JM
J Virol; 2004 Aug; 78(15):8201-9. PubMed ID: 15254191
[TBL] [Abstract][Full Text] [Related]
9. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.
Delos SE; Godby JA; White JM
J Virol; 2005 Mar; 79(6):3488-99. PubMed ID: 15731243
[TBL] [Abstract][Full Text] [Related]
10. The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.
Earp LJ; Delos SE; Netter RC; Bates P; White JM
J Virol; 2003 Mar; 77(5):3058-66. PubMed ID: 12584331
[TBL] [Abstract][Full Text] [Related]
11. Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits.
Damico R; Rong L; Bates P
J Virol; 1999 Apr; 73(4):3087-94. PubMed ID: 10074159
[TBL] [Abstract][Full Text] [Related]
12. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
Netter RC; Amberg SM; Balliet JW; Biscone MJ; Vermeulen A; Earp LJ; White JM; Bates P
J Virol; 2004 Dec; 78(24):13430-9. PubMed ID: 15564453
[TBL] [Abstract][Full Text] [Related]
13. The hr1 and fusion peptide regions of the subgroup B avian sarcoma and leukosis virus envelope glycoprotein influence low pH-dependent membrane fusion.
Babel AR; Bruce J; Young JA
PLoS One; 2007 Jan; 2(1):e171. PubMed ID: 17245447
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of a fusion glycoprotein from a retrovirus that undergoes a hybrid 2-step entry mechanism.
Aydin H; Smrke BM; Lee JE
FASEB J; 2013 Dec; 27(12):5059-71. PubMed ID: 24036886
[TBL] [Abstract][Full Text] [Related]
15. Simple, automated, high resolution mass spectrometry method to determine the disulfide bond and glycosylation patterns of a complex protein: subgroup A avian sarcoma and leukosis virus envelope glycoprotein.
Pike GM; Madden BJ; Melder DC; Charlesworth MC; Federspiel MJ
J Biol Chem; 2011 May; 286(20):17954-67. PubMed ID: 21454567
[TBL] [Abstract][Full Text] [Related]
16. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
Melder DC; Pike GM; VanBrocklin MW; Federspiel MJ
J Virol; 2015 Feb; 89(4):2136-48. PubMed ID: 25473063
[TBL] [Abstract][Full Text] [Related]
17. Alpharetrovirus envelope-receptor interactions.
Barnard RJ; Young JA
Curr Top Microbiol Immunol; 2003; 281():107-36. PubMed ID: 12932076
[TBL] [Abstract][Full Text] [Related]
18. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.
Ochsenbauer-Jambor C; Delos SE; Accavitti MA; White JM; Hunter E
J Virol; 2002 Aug; 76(15):7518-27. PubMed ID: 12097564
[TBL] [Abstract][Full Text] [Related]
19. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth.
Melikyan GB; Barnard RJ; Markosyan RM; Young JA; Cohen FS
J Virol; 2004 Apr; 78(7):3753-62. PubMed ID: 15016895
[TBL] [Abstract][Full Text] [Related]
20. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
Celma CC; Paladino MG; González SA; Affranchino JL
Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]